Advertisement
For patients with hepatocellular carcinoma

Percutaneous Ablation in Liver Cancer Tied to Better Outcomes

0
Intervention linked to better short-term outcomes versus surgical procedures
EndoPredict is prognostic for distant recurrence in women with estrogen receptor-positive

Test Predicts Benefit of Chemo in ER+, HER2− Breast Cancer

0
EndoPredict, a multigene test, helps predict whether adjuvant chemotherapy would be beneficial
For patients with symptomatic pulmonary embolism

Patent Foramen Ovale Ups Ischemic Stroke in Those With PE

0
Frequency of ischemic stroke increased in association with patent foramen ovale in symptomatic PE
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
Complication rates for nipple-sparing mastectomy are decreasing despite expanded indications for the procedure among higher-risk patients

Less Invasive Mastectomy an Option for More Patients

0
Higher-risk patients may now be eligible for nipple-sparing mastectomy

American Urological Association, May 3-6

0
The American Urological Association 2019 Annual Meeting The annual meeting of the American Urological Association was held from May 3 to 6 in...
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

0
Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
For patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer

New Lesions ID’d on Breast MRI During Treatment Likely Benign

0
New suspicious lesions detected on breast MRI during neoadjuvant therapy are more likely benign
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs
Efforts are needed to ensure all completed large trials are reported

Efforts Needed to Ensure Publication of All Trials

0
67 trials ID'd that were unreported for median of nine years after completion, with 87,883 participants